Difluprednate Emulsion
Product Images NDC 46708-750

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Difluprednate (NDC 46708-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Difluprednate-bottle-label-ltd (Difluprednate Bottle Label Ltd)

Label for Difluprednate Ophthalmic Emulsion 0.05%, a sterile ophthalmic drug in 5 mL packaging by Alembic Pharmaceuticals Limited. The label includes the active ingredient concentration, manufacturer information, barcode, and space for lot number and expiration date. It is designated for prescription use only.*

FDA Label Image

Difluprednate-carton-limited (Difluprednate Carton Limited)

Packaging label for Difluprednate Ophthalmic Emulsion 0.05%, a sterile eye drop solution in a 5 mL bottle. The label shows the product name, strength, dosage form, and intended ophthalmic use. It includes the NDC 46708-750-05, manufacturer Alembic Pharmaceuticals Limited, and storage instructions. The label features an eye graphic and highlights the prescription-only status.*

FDA Label Image

Difluprednate-figure-1 (Difluprednate Figure 1)

A bar graph showing the percent of subjects with anterior chamber cells clearing (cell count = 0) on Day 8 and Day 15. The graph compares Difluprednate ophthalmic emulsion QID (n=107) and placebo (n=220), indicating higher clearance percentages with Difluprednate on both days, with statistical significance (P<0.05).*

FDA Label Image

Difluprednate-figure-2 (Difluprednate Figure 2)

A bar chart showing the percent of subjects who were pain free over three time points: Day 3, Day 8, and Day 15. It compares Difluprednate ophthalmic emulsion QID (n=107) and placebo (n=220). Difluprednate results are higher at all time points (45%, 58%, and 63%) compared to placebo (25%, 27%, and 35%), with statistical significance indicated (P<0.05).*

FDA Label Image

Difluprednate-structure (Difluprednate Structure)

Chemical structure of difluprednate, the active ingredient in Difluprednate ophthalmic emulsion 0.5 mg/mL by Alembic Pharmaceuticals Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.